Bio-Rad Laboratories Class B
BIO.B
6 hedge funds and large institutions have $6.6M invested in Bio-Rad Laboratories Class B in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0.13% less ownership
Funds ownership: 0.35% → 0.22% (-0.13%)
14% less funds holding
Funds holding: 7 → 6 (-1)
29% less capital invested
Capital invested by funds: $9.24M → $6.6M (-$2.64M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$3.56M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$154K |
| 3 |
Renaissance Technologies
New York
|
-$57.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $4.3M | -$3.56M | -6,213 | -46% |
|
|
2
Renaissance Technologies
New York
| $1.67M | -$57.2K | -100 | -3% |
|
3
Morgan Stanley
New York
| $403K | – | – | – |
|
|
GAM
4
Gemmer Asset Management
Walnut Creek,
California
| $174K | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $33K | – | – | – |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $30K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$154K | -303 | Closed |
|
BIO.B Hedge Fund Activity: Q4 2020 in Review
6 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2020, worth a combined $6.6M — down 29% from $9.24M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIO.B and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was CSS LLC, cutting an estimated $3.56M.
- 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2020, down from 7 in Q3 2020.
- Funds reported $6.6M of Bio-Rad Laboratories Class B stock for Q4 2020, down 29% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q4 2020 and 1 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class B seller in Q4 2020 was CSS LLC, an estimated $3.56M sold.
Based on aggregated 13F filings for Q4 2020.